医生经验对在门诊实践中的老年耳鼻科护理的影响
Dorota Świątek1, Wioletta Pietruszewska2, Kamila Sroka3
1Department of Otolaryngology, Regional Specialist Hospital Wroclaw, Research & Development Centre, Wroclaw, Poland.
Otolaryngologia polska = The Polish otolaryngology
|October 31, 2025
概括
医生的经验会影响老年耳鼻喉 (ENT) 护理. 高级医生更好地识别疾病和副作用,而职业生涯早期的医生则主张专用服务,并面临进入障碍.
科学领域:
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 老年医学 老年医学
背景情况:
- 全球人口老龄化,增加了对老年患者专业护理的需求.
- 医生经验对于管理复杂的患者群体,包括老年人至关重要.
研究的目的:
- 评估医生的经验,多年的实践经验和病例负载如何影响老年患者门诊耳鼻喉治疗的质量.
主要方法:
- 在全国范围内对115名波兰耳鼻喉 (ENT) 医生进行了在线调查.
- 收集的数据包括医生经验,老年患者数量和护理需求,使用奇方位和费舍尔精确测试进行分析.
主要成果:
- 耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳,耳
- 高级医生报告说,老年人耳鼻喉病例数量更高,药物副作用的识别能力更好.
- 早期职业生涯的医生更喜欢专门的老年耳鼻科服务,并且报告了更多的访问障碍困难.
结论:
- 医生的经验对老年患者识别耳鼻关节疾病和副作用有重大影响.
- 年轻的医生更支持专门的老年耳鼻喉服务,而年长的医生表现出更强大的临床判断力.
- 对于定制的老年治疗策略和在门诊ENT环境中进行培训的需要达成共识,以满足老年人日益增长的需求.
相关概念视频
Drug Dosing: Geriatric Patients
217
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
217
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
218
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
218
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
229
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
229
Pharmacodynamics in Geriatric Patients: Effects of Age
182
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
182
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
224
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
224
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
192
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
192

